[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

David Moatazedi Biography and Net Worth

Insider of Evolus

David Moatazedi is the President and Chief Executive Officer of Evolus (NASDAQ: EOLS). Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Jeuveau® is powered by Evolus' unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today.breakthrough products.

David has nearly twenty years of commercial and executive experience building multiple market leading brands, including his most recent tenure as Senior Vice President of U.S. Medical Aesthetics at Allergan™ where he led the Medical aesthetic portfolio and several multi-billion-dollar acquisitions. David also currently sits on the board of Obalon Therapeutics (NASDAQ: OBLN).

He holds an MBA in Marketing from Pepperdine University and a B.A. in Chemistry from California State University, Long Beach. David resides in Newport Beach with his wife and three children.

What is David Moatazedi's net worth?: The estimated net worth of David Moatazedi is at least $7.21 million as of June 5th, 2024. Mr. Moatazedi owns 533,349 shares of Evolus stock worth more than $7,205,545 as of December 3rd. This net worth evaluation does not reflect any other investments that Mr. Moatazedi may own. Additionally, Mr. Moatazedi receives a salary of $1,750,000.00 as Insider at Evolus. Learn More about David Moatazedi's net worth.
How old is David Moatazedi?: Mr. Moatazedi is currently 46 years old. There are 1 older executives and no younger executives at Evolus. Learn More on David Moatazedi's age.
What is David Moatazedi's salary?: As the Insider of Evolus, Inc., Mr. Moatazedi earns $1,750,000.00 per year. Learn More on David Moatazedi's salary.
How do I contact David Moatazedi?: The corporate mailing address for Mr. Moatazedi and other Evolus executives is 520 Newport Center Dr. Suite 1200, Newport Beach CA, 92660. Evolus can also be reached via phone at (949) 284-4555 and via email at [email protected]. Learn More on David Moatazedi's contact information.
Has David Moatazedi been buying or selling shares of Evolus?: David Moatazedi has not been actively trading shares of Evolus within the last three months. Most recently, David Moatazedi sold 155,278 shares of the business's stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $12.92, for a transaction totalling $2,006,191.76. Following the completion of the sale, the insider now directly owns 533,349 shares of the company's stock, valued at $6,890,869.08. Learn More on David Moatazedi's trading history.
Who are Evolus' active insiders?: Evolus' insider roster includes Rui Avelar (Insider), Vikram Malik (Director), and David Moatazedi (Insider). Learn More on Evolus' active insiders.
Are insiders buying or selling shares of Evolus?: During the last twelve months, insiders at the sold shares 15 times. They sold a total of 337,419 shares worth more than $4,176,701.61. The most recent insider tranaction occured on September, 6th when CFO Sandra Beaver sold 3,276 shares worth more than $49,074.48. Insiders at Evolus own 6.1% of the company. Learn More about insider trades at Evolus.
Information on this page was last updated on 9/6/2024.

David Moatazedi Insider Trading History at Evolus

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/5/2024	Sell	155,278	$12.92	$2,006,191.76	533,349
5/10/2024	Sell	16,051	$12.72	$204,168.72	673,563
3/27/2024	Sell	6,236	$13.86	$86,430.96	689,614
2/22/2024	Sell	7,706	$13.08	$100,794.48	792,416
12/8/2023	Sell	31,300	$9.73	$304,549.00	603,944
12/6/2023	Sell	51,348	$10.09	$518,101.32	635,244
3/27/2023	Sell	6,110	$8.47	$51,751.70	609,567
3/14/2023	Sell	64,211	$8.47	$543,867.17	615,677
5/16/2022	Sell	55,321	$13.64	$754,578.44	491,961
3/28/2022	Sell	6,104	$11.62	$70,928.48
3/8/2022	Sell	37,972	$9.73	$369,467.56
8/16/2021	Sell	47,737	$11.35	$541,814.95	424,809
8/13/2021	Sell	22,708	$10.66	$242,067.28

David Moatazedi Buying and Selling Activity at Evolus

Evolus Company Overview

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Today's Range

Now: $13.55

$13.44

$13.63

50 Day Range

MA: $15.22

$11.88

$17.45

2 Week Range

Now: $13.55

$9.38

$17.82

Volume

89,676 shs

Average Volume

592,355 shs

Market Capitalization

$857.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

David Moatazedi Biography and Net Worth

What is David Moatazedi's net worth?

How old is David Moatazedi?

What is David Moatazedi's salary?

How do I contact David Moatazedi?

Has David Moatazedi been buying or selling shares of Evolus?

Who are Evolus' active insiders?

Are insiders buying or selling shares of Evolus?